Yeast Metabolic Production of Cannabigerolic Acid

Solution Overview

Problem

Current methods for producing cannabinoids, such as chemical synthesis and extraction from Cannabis sativa, face challenges including high costs, environmental concerns, and difficulties in reproducing consistent cannabinoid profiles, leading to impurities in pharmaceutical products.

Innovation Solution

Genetic engineering of yeast to produce specific cannabinoids by inserting genes that encode enzymes for metabolic pathways, allowing for the production of cannabinoids like cannabidiol and tetrahydrocannabinolic acid from simple sugar sources, resulting in a cost-effective, sustainable, and pure production process.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If chemical synthesis is used to produce cannabinoids, then production cost is reduced, but product purity decreases and environmental harm increases

Engineering Contradiction:
Core Design Contradiction:
Ease of manufactureVSManufacturing precision

Solution Approach 1:

The patent uses genetically engineered yeast cells as a biological intermediary system to produce cannabinoids. The yeast contains introduced plant genes that encode enzymes for cannabinoid biosynthesis, serving as a living factory that converts simple sugars into pure cannabinoids through metabolic pathways, avoiding both chemical synthesis impurities and plant extraction complexities

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent replaces mechanical/chemical extraction methods with biological production. Instead of using solvents and chemical processes to extract cannabinoids from plants, the system uses genetically modified yeast to biosynthesize cannabinoids de novo through enzymatic reactions, substituting chemical mechanics with biological metabolism

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Ease of manufacture

If chemical synthesis is used to produce cannabinoids, then production cost is reduced, but environmental harm increases

Engineering Contradiction:
Core Design Contradiction:
Ease of manufactureVSObject-affected harmful factors

Solution Approach 1:

The patent replaces chemical synthesis and plant extraction methods with biological production in yeast. This substitution eliminates the need for harmful chemical solvents and processing agents, using instead enzymatic reactions within living cells that are inherently more environmentally benign

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the fundamental production parameter from chemical/physical extraction to biological synthesis. By introducing plant cannabinoid biosynthesis genes into yeast and providing simple sugar substrates, the system transforms the production mechanism to one that operates under mild biological conditions rather than harsh chemical conditions

Inventive Principle:
Principle #35Parameter changes

3Manufacturing precision

If plant extraction is used to obtain cannabinoids, then product purity is improved, but production cost increases and consistency is reduced

Engineering Contradiction:
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The patent extracts the essential cannabinoid biosynthesis capability from plant cells and transfers it into yeast cells. By taking out the specific genes encoding cannabinoid enzymes and relocating them to a different host organism, the system achieves pure cannabinoid production without the need to extract from complex plant matrices

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent creates a copy of the plant cannabinoid biosynthesis pathway within yeast cells. By introducing plant genes that encode the enzymatic machinery for cannabinoid production, the yeast becomes a surrogate production system that replicates plant metabolism without the associated impurities and variability

Inventive Principle:
Principle #26Copying

4Manufacturing precision

If plant extraction is used to obtain cannabinoids, then product purity is improved, but production cost increases

Engineering Contradiction:
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The patent introduces a microbial intermediary system (genetically engineered yeast) that produces cannabinoids through biological synthesis. This intermediary approach achieves high purity comparable to plant extraction but at lower cost by using simpler substrates and more efficient production biology

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the production substrate from complex plant material to simple sugars. By feeding yeast with basic carbon sources and relying on the introduced biosynthetic pathway, the system reduces material costs and simplifies the production input requirements while maintaining high product purity

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method enables reliable and cost-effective production of pure cannabinoids, overcoming the challenges of consistency and environmental impact, with the potential for wide-ranging health applications.

Implementation Method 1

genetic engineering of yeast to produce specific cannabinoids by inserting genes that encode enzymes for metabolic pathways, allowing for the production of cannabinoids like cannabidiol and tetrahydrocannabinolic acid from simple sugar sources

Methodology Applied
Scientific EffectMetabolic pathway: Fermentation

Data Source

PatentUS10954534B2Production of cannabigerolic acid in yeast
Publication Date: 2021.03.23
  • US10954534B2 patent drawing
  • US10954534B2 patent drawing
  • US10954534B2 patent drawing

AI summary

Exemplary embodiments provided herein include genetically engineering microorganisms, such as yeast or bacteria, to produce cannabinoids by inserting genes that produce the appropriate enzymes for the metabolic production of a desired compound.